The LINX System

Call us on 020 8901 5505 to find out more or to book an appointment

Spire Bushey Hospital is offering a new treatment for chronic reflux disease (GORD) using the LINX System.

What is Gastro-Oesophageal Reflux Disease (GORD)?

Gastro-Oesophageal Reflux Disease (GORD) is a chronic, often progressive condition resulting from a weak Lower Oesophageal Sphincter (LOS) allowing acid and bile to flow back or 'reflux' from the stomach into the oesophagus.

People experience symptoms of GORD in a variety of ways. The most common symptom of GORD is heartburn, but symptoms may also include regurgitation, sore throat, cough and chest pain.

If left untreated in some cases serious complications can occur, such as oesophagitis, swallowing difficulties, Barrett’s oesophagus (a pre-cancerous condition) and oesophageal cancer.

Who is affected

GORD is a common digestive condition and can affect people of all ages, including children. However, most cases affect adults aged 40 or over. GORD is thought to affect both women and men equally, but males are more likely to develop complications.

The LINX System

The LINX System offers a new treatment option for GORD, reducing or eliminating symptoms through a simple, reversible procedure using laparoscopy or keyhole surgery.

The LINX System is a small, flexible band of interlinked titanium beads with magnetic cores that helps the LOS resist opening to gastric pressures, creating a barrier to the reflux of acid and bile.

Swallowing temporarily breaks the magnetic bond to allow food and drink to pass normally through the LOS. The magnets then close the LOS immediately after swallowing to restore the body's natural barrier to the reflux of acid and bile.

The procedure

The LINX System is suitable for people who have suffered from GORD for a number of years, who respond partially to medication. In addition, the indivudal should be able to swallow normally and have a healthy oesophagus (e.g. no Barrett's)

Following a consultation with Consultant Bariatric Surgon Mr Pratik Sufi, a number of tests including a gastroscopy will be carried out to check patient suitability for treatment. 

If patients are suitable for treatment, they will come into hospital for the procedure where the LINX System is placed around the oesophagus just above the stomach using a common, minimally invasive surgical technique called laparoscopy or keyhole surgery.

Patients are placed under general anaesthesia during the procedure, which is generally completed in less than an hour. Once placed, the device will begin working immediately. Patients usually spend the night in hospital and go home the next day. Following the procedure, under our consultant's guidance, patients should be able to resume a normal diet and will typically resume normal activities in less than a week.

Side effects

Side effects are generally minimal and resolve over time. Our consultant will be able to give you comprehensive information.

Our consultants  

Consultant Bariatric Surgeon Mr Pratik Sufi provides the LINX treatment at Spire Bushey Hospital.

For more information or to book an appointment please call 020 8901 5505.

LINX symptom checker

If you suffer from two or more of the following you may benefit from the LINX procedure:

  • Heartburn
  • Regurgitation
  • Nausea
  • Cough
  • Asthma
  • Sore mouth or tongue
  • ENT problems
  • Upper abdominal pain
  • Poor response to anti-acid medications
  • Unwilling to take anti-acid medications long-term

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

This video demonstrates how the LINX System works

© Spire Healthcare Group plc (2016)